List of ZONTAL Customers
Provo, 33324, UT,
United States
Since 2010, our global team of researchers has been studying ZONTAL customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased ZONTAL for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using ZONTAL for Laboratory Management include: Regeneron Pharmaceuticals, a United States based Life Sciences organisation with 15182 employees and revenues of $142.02 billion, Johnson & Johnson, a United States based Life Sciences organisation with 138100 employees and revenues of $88.82 billion, AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Merck, a United States based Life Sciences organisation with 73000 employees and revenues of $64.17 billion, Bayer, a Germany based Life Sciences organisation with 92815 employees and revenues of $55.47 billion and many others.
Contact us if you need a completed and verified list of companies using ZONTAL, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The ZONTAL customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | ZONTAL | ZONTAL | Laboratory Management | 2023 | n/a |
In 2023, AstraZeneca deployed ZONTAL as its Scientific Data Management Platform for a UK Laboratory Management implementation. The programme established an SDMS data model rooted in FAIR data principles, orienting metadata strategy and structured data capture for R&D laboratory outputs.
The ZONTAL implementation concentrated on core Laboratory Management capabilities, including standardized metadata capture, a governed scientific data model, data ingestion and indexing, cataloging for discovery, and access controls and audit trails aligned with research compliance requirements. Configuration work focused on mapping required metadata fields and taxonomies to ensure data items stored in ZONTAL carried the contextual metadata necessary for reuse and provenance.
Operational scope covered United Kingdom R&D laboratory teams, with delivery activities that included workshops to document As is and To be processes, capture business requirements, and specify associated metadata for datasets to be retained in ZONTAL. The project team included business analysts and technical engineers working under a central project manager to align laboratory operations, data stewardship, and scientific workflows with the new SDMS.
Project governance was run using agile practices, with daily scrums, backlog grooming, and sprint planning to drive incremental configuration and demos. Rollout activities emphasized training, stakeholder communications, and business change management to embed ZONTAL into lab workflows, while requirement capture and regular demonstrations were used to validate configuration against R&D needs.
|
|
|
AstraZeneca Sweden | Life Sciences | 8000 | $1.7B | Sweden | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
In 2020, AstraZeneca Sweden implemented ZONTAL as its Laboratory Management platform for R&D labs. The ZONTAL deployment formed a core element of an enterprise lab data initiative centered on an Accessible Lab Data Platform.
The implementation was integrated into an Accessible Lab Data Platform and a data lake hosted in AWS cloud, supporting more than 2500 instruments and roughly 6000 scientists globally. ZONTAL was implemented with explicit data pipelines, data engineering and analytical capabilities, and the project included integration with Revvity Signals ELN to streamline laboratory records and experiment data flows.
Governance and architecture were formalized through reference architecture and design patterns, data stewardship processes, and compliance checks aligned to ALCOA plus principles, FAIR data principles, ISO27001 and SAFe architecture principles. The platform was qualified for business use with the necessary IT artefacts, and the implementation targeted R&D laboratory data management, lab informatics standardization and enterprise data governance.
|
 |
Bayer | Life Sciences | 92815 | $55.5B | Germany | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
In 2020, Bayer deployed ZONTAL as its Laboratory Management solution to standardize laboratory operations and quality workflows across its life sciences organization. The deployment targeted laboratory operations and quality assurance functions, aligning ZONTAL with compliance and sample lifecycle management requirements within Bayer’s research and testing environments.
ZONTAL was configured to provide core Laboratory Management capabilities, including sample lifecycle tracking, instrument and inventory management, workflow orchestration, electronic audit trails, and compliance reporting. The ZONTAL implementation emphasized configurable workflows and role based access controls consistent with laboratory informatics practices, enabling controlled data capture and traceability.
Auditors evaluated the implementation in the context of Bayer’s broader IT and compliance landscape and reported that ZONTAL demonstrated effective interoperability with existing processes and governance models, without naming specific integrations. The review covered operational controls and system maturity across laboratory and quality functions and confirmed alignment with regulatory readiness expectations.
The audit concluded with no critical or major findings, stating that ZONTAL was fully compliant with all items reviewed. Auditors expressed a high degree of confidence in the maturity of Bayer’s systems and their ability to collaborate within complex IT and compliance landscapes, noting well-established services and operational governance around the ZONTAL Laboratory Management deployment.
|
 |
|
Life Sciences | 1300 | $270M | Germany | ZONTAL | ZONTAL | Laboratory Management | 2023 | n/a |
|
|
|
|
Life Sciences | 6389 | $2.5B | Italy | ZONTAL | ZONTAL | Laboratory Management | 2018 | n/a |
|
|
|
|
Life Sciences | 1309 | $513M | Belgium | ZONTAL | ZONTAL | Laboratory Management | 2021 | n/a |
|
|
|
|
Life Sciences | 2635 | $2.3B | Denmark | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
|
|
|
|
Life Sciences | 138100 | $88.8B | United States | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
|
|
|
|
Oil, Gas and Chemicals | 11685 | $16.7B | United Kingdom | ZONTAL | ZONTAL | Laboratory Management | 2018 | n/a |
|
|
|
|
Life Sciences | 73000 | $64.2B | United States | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
|
Buyer Intent: Companies Evaluating ZONTAL
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||